Development of cancer specific viral vector for carcinoma by inducing the plural genes
Development of cancer specific viral vector for carcinoma by inducing the plural genes
批准号:
13470230
负责人:
KONDO Satoshi
金额:
$8.96万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
我们研究了在几种器官肿瘤中表达的肿瘤特异性抗原。胰腺癌组织中RCAS1基因阳性率为90%。此外,RCAS1基因过表达与胰腺癌、肝外胆管癌、食道癌患者的预后相关。小窝蛋白-1的表达也与胰腺癌患者的预后有关。我们构建了由RCAS1启动子(Ad RCAS1-KLAK2,Ad RCAS1-Bax)或SCCA启动子(Ad SCCA-KLAKLAK2)驱动的复制缺陷重组KLAKLAK2或Bax重组腺病毒。我们发现,KLAKLAK2的表达和生长抑制都是SCCA阳性的癌细胞所特有的,而在人正常细胞系中,感染后没有观察到生长抑制。
英文摘要
We studied the cancer specific antigens expressed in the several organ tumors. In pancreatic cancer, 90% were positive for RCAS1 gene. Moreover, overexpression of RCAS1 gene was correlated with the prognosis of patients with pancreatic cancer, extrahepatic bile duct carcinoma and esophageal cancer. Caveolin-1 expression was also correlated with with the prognosis of patients with pancreatic cancer.We made a replication-deficient recombinant KLAKLAK2 or Bax adenovirus driven by the RCAS1promoter (Ad RCAS1-KLAKLAK2, Ad RCAS1-Bax) or the SCCA promoter (Ad SCCA-KLAKLAK2). We demonstrated that the expression of KLAKLAK2 and growth inhibition were all specific to the cancer cell lines that were SCCA positive, whereas no growth retardation was observed in human normal cell lines after Ad SCCA-KLAKLAK2 infection.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Tetsuro Takebayashi: "NF-kB-dependent induction of cyclinD1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants"The Journal of Biological Chemistry. 278・17. 14897-14905 (2003)
Tetsuro Takebayashi:“视网膜母细胞瘤蛋白 (pRB) 家族蛋白和肿瘤衍生的 pRB 突变体对细胞周期蛋白 D1 的 NF-kB 依赖性诱导”《生物化学杂志》278・17 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Oshikiri T: "RCAS1 as a tumour progression marker : an independent negative prognostic factor in gallbladder cancer"Br J Cancer. 85(12). 1922-1927 (2001)
Oshikiri T:“RCAS1 作为肿瘤进展标志物:胆囊癌的独立负面预后因素”Br J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hiraoka K: "High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker"Int J Cancer. 99. 418-423 (2002)
Hiraoka K:“胰腺导管腺癌中肿瘤相关抗原 RCAS1 的高表达是一个不利的预后标志物”Int J Cancer。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masato Suzuoki: "Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma"British Journal of Cancer. 87. 1140-1144 (2002)
Masato Suzuoki:“caveolin-1 表达对胰腺导管腺癌预后的影响”英国癌症杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Masato Suzuoki: "RCAS1 expression as a prognositc factor after curative surgery for extrahepatic bile duct carcinoma"Annals of Surgical Oncology. 9. 388-392 (2002)
Masato Suzuoki:“RCAS1 表达作为肝外胆管癌根治性手术后的预后因素”《肿瘤外科年鉴》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 16 条
Care of senile dementia people by using skill of occupational therapy: developing a practical tool with their capabilities
-
批准号:24659328
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$0.92万
-
财政年份:2012
-
负责人:KONDO Satoshi
-
依托单位:
On the special values of the product of L-functions and the periods of automorphic forms defined over function fields
-
批准号:21654002
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.1万
-
财政年份:2009
-
负责人:KONDO Satoshi
-
依托单位:
Clinical trial of cancer vaccine using NY-ESO-1/CpG
-
批准号:18390356
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.67万
-
财政年份:2006
-
负责人:KONDO Satoshi
-
依托单位:
Clinical approach of cancer of the esophagus specific treatment based on an individualization of a gene expression pattern
-
批准号:16390387
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.06万
-
财政年份:2004
-
负责人:KONDO Satoshi
-
依托单位:
The research about overexpression gene identification with neuroblastoma on Biochip
-
批准号:14571705
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:2002
-
负责人:KONDO Satoshi
-
依托单位:
Analysis of the candidate tumor suppressor ING1 gene in neuroblastoma.
-
批准号:12671740
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.79万
-
财政年份:2000
-
负责人:KONDO Satoshi
-
依托单位:
Gene therapy for metastatic colon cancer in the liver by using CEA promoter
-
批准号:11671140
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:KONDO Satoshi
-
依托单位:
海外基金